Polymeric enhancers of mucosal epithelia permeability: Synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues

被引:81
作者
Di Colo, Giacomo [1 ]
Zambito, Ylenia [1 ]
Zaino, Chiara [1 ]
机构
[1] Univ Pisa, Dept Bioorgan Chem & Bippharmaceut, I-56126 Pisa, Italy
关键词
transmucosal drug delivery; absorption enhancer; permeation enhancer; polymeric biomaterials; polymer synthesis; chitosan; paracellular transport; transcellular transport; tight junction; toxicity;
D O I
10.1002/jps.21043
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Transmucosal drug administration across nasal, buccal, and ocular mucosae is noninvasive, eliminates hepatic first-pass metabolism and harsh environmental conditions, allows rapid onset, and further, mucosal surfaces are readily accessible. Generally, however, hydrophilic drugs, such as peptides and proteins, are poorly permeable across the epithelium, which results in insufficient bioavailability. Therefore, reversible modifications of epithelial barrier structure by permeation enhancers are required. Low molecular weight enhancers generally have physicochemical characteristics favoring their own absorption, whereas polymeric enhancers are not absorbed, and this minimizes the risk of systemic toxicity. The above considerations have warranted the present survey of the studies on polymeric transmucosal penetration-enhancers that have appeared in the literature during the last decade. Studies on intestinal permeation enhancers are also reviewed as they give information on the mechanism of action and safety of polymers. The synthesis and characterization of polymers, their effectiveness in enhancing the absorption of different drugs across different epithelium types, their mechanism of action and structure-efficacy relationship, and the relevant safety issues are reviewed. The active polymers are classified into: polycations (chitosan and its quaternary ammonium derivatives, poly-L-arginine (poly-L-Arg), aminated gelatin), polyanions (N-carboxymethyl chitosan, poly(acrylic acid)), and thiolated polymers (carboxymethyl cellulose-cysteine, polycarbophil (PCP)-cysteine, chitosan-thiobutylamidine, chitosan-thioglycolic acid, chitosan-glutathione conjugates). (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1652 / 1680
页数:29
相关论文
共 128 条
[21]   Effect of chitosan on epithelial permeability and structure [J].
Dodane, V ;
Khan, MA ;
Merwin, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :21-32
[22]  
Durmaz B, 1997, ARZNEIMITTEL-FORSCH, V47, P413
[23]  
FELT G, 2001, AAPS PHARMSCI, V3, pE34
[24]   Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention [J].
Felt, O ;
Furrer, P ;
Mayer, JM ;
Plazonnet, B ;
Buri, P ;
Gurny, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (02) :185-193
[25]   Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation [J].
Florea, BI ;
Thanou, M ;
Junginger, HE ;
Borchard, G .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :353-361
[26]   Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers [J].
González-Mariscal, L ;
Nava, P ;
Hernández, S .
JOURNAL OF MEMBRANE BIOLOGY, 2005, 207 (02) :55-68
[27]   METABOLISM OF EXTRACELLULAR GLUTATHIONE IN RAT SMALL-INTESTINAL MUCOSA [J].
GRAFSTROM, R ;
STEAD, AH ;
ORRENIUS, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1980, 106 (02) :571-577
[28]   In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix [J].
Guggi, D ;
Kast, CE ;
Bernkop-Schnürch, A .
PHARMACEUTICAL RESEARCH, 2003, 20 (12) :1989-1994
[29]   Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement:: in vivo evaluation in rat nasal epithelia [J].
Hamman, JH ;
Stander, M ;
Kotzé, AF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) :235-242
[30]   N-trimethyl chitosan chloride:: Optimum degree of quaternization for drug absorption enhancement across epithelial cells [J].
Hamman, JH ;
Schultz, CM ;
Kotzé, AF .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (02) :161-172